ReviewCancers2023

Resistance to Antibody-Drug Conjugates Targeting HER2 in Breast Cancer: Molecular Landscape and Future Challenges.

Lorenzo Guidi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.